About the Company
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AKTX News
Akari Therapeutics, Plc (AKTX)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Akari Therapeutics PLC ADR
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases.
Geriatric Medicines Market Size Future Scope, Demands and Projected Industry Growths 2023- 2033
The geriatric medicines market studied was anticipated to witness a CAGR of nearly 6.5% during the forecast period.
Latest Press Releases
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our ...
Propulsion of Asthma Pipeline as Novel and Extensive 95+ Therapies Likely to Enter in the Treatment Domain | DelveInsight
DelveInsight's 'Asthma Pipeline Insight - 2023'report provides comprehensive global coverage of available, marketed, and pipeline asthma therapies in various stages of clinical development, major ...
Akari Therapeutics PLC ADR
1 Day AKTX 4.82% DJIA -1.02% Russell 2K -0.92% Health Care/Life Sciences -0.05% ...
Akari Therapeutics, Plc (AKTX)
*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Akari Therapeutics PLC ADR
1 Day AKTX -10.88% DJIA -2.04% Russell 2K -3.21% Health Care/Life Sciences 1.29% ...
Akari Therapeutics, Plc (AKTX)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Akari Therapeutics plc ADS (AKTX)
Nasdaq Official Closing Price (NOCP)" is a process for identifying the Nasdaq market-specific closing price for Nasdaq-listed issues. Data provided by Nasdaq Data Link, a premier source for ...
Loading the latest forecasts...